Finding the Missing Links among Metabolites, Microbes, and the Host

Immunity

Volumn 40, Issue 6, 2014, Pages 824-832

  Dorrestein, Pieter C ^a,b   Mazmanian, Sarkis K ^c   Knight, Rob ^d,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c California Institute of Technology   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT;

GENE CLUSTER; HOST; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLITE; METABOLOME; METABOLOMICS; MICROBIAL DIVERSITY; MICROBIAL METABOLISM; MICROBIOME; MICROORGANISM; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; REVIEW;

BACTERIAL PROTEINS; GASTROINTESTINAL TRACT; HUMANS; METABOLOME; METAGENOME; MICROBIOTA;

EID: 84902657623     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.05.015     Document Type: Review

References (75)

1. Abt M.C., Osborne L.C., Monticelli L.A., Doering T.A., Alenghat T., Sonnenberg G.F., Paley M.A., Antenus M., Williams K.L., Erikson J., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
2. Baganz N.L., Blakely R.D. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci 2013, 4:48-63.
3. Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
4. Caporaso J.G., Lauber C.L., Costello E.K., Berg-Lyons D., Gonzalez A., Stombaugh J., Knights D., Gajer P., Ravel J., Fierer N., et al. Moving pictures of the human microbiome. Genome Biol. 2011, 12:R50.
5. Carvalho F.A., Koren O., Goodrich J.K., Johansson M.E., Nalbantoglu I., Aitken J.D., Su Y., Chassaing B., Walters W.A., González A., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012, 12:139-152.
6. Carvalho F.A., Nalbantoglu I., Ortega-Fernandez S., Aitken J.D., Su Y., Koren O., Walters W.A., Knight R., Ley R.E., Vijay-Kumar M., Gewirtz A.T. Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 2012, 61:373-384.
7. Chu H., Mazmanian S.K. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat. Immunol. 2013, 14:668-675.
8. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
9. Clayton T.A., Baker D., Lindon J.C., Everett J.R., Nicholson J.K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 2009, 106:14728-14733.
10. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
11. Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., Almeida M., Quinquis B., Levenez F., Galleron N., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588. ANR MicroObes consortium.
12. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13:701-712.
13. Eberhard J., Jepsen S., Pohl L., Albers H.K., Açil Y. Bacterial challenge stimulates formation of arachidonic acid metabolites by human keratinocytes and neutrophils invitro. Clin. Diagn. Lab. Immunol. 2002, 9:132-137.
14. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
15. Faith J.J., Guruge J.L., Charbonneau M., Subramanian S., Seedorf H., Goodman A.L., Clemente J.C., Knight R., Heath A.C., Leibel R.L., et al. The long-term stability of the human gut microbiota. Science 2013, 341:1237439.
16. Fierer N., Lauber C.L., Zhou N., McDonald D., Costello E.K., Knight R. Forensic identification using skin bacterial communities. Proc. Natl. Acad. Sci. USA 2010, 107:6477-6481.
17. Findley K., Oh J., Yang J., Conlan S., Deming C., Meyer J.A., Schoenfeld D., Nomicos E., Park M., Kong H.H., Segre J.A. Topographic diversity of fungal and bacterial communities in human skin. Nature 2013, 498:367-370. NIH Intramural Sequencing Center Comparative Sequencing Program.
18. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104:13780-13785.
19. Frank D.N., Robertson C.E., Hamm C.M., Kpadeh Z., Zhang T., Chen H., Zhu W., Sartor R.B., Boedeker E.C., Harpaz N., et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 2011, 17:179-184.
20. Fuchs O., von Mutius E. Prenatal and childhood infections: implications for the development and treatment of childhood asthma. Lancet Respir Med 2013, 1:743-754.
21. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory Tcells. Nature 2013, 504:446-450.
22. Gevers D., Kugathasan S., Denson L.A., Vázquez-Baeza Y., Van Treuren W., Ren B., Schwager E., Knights D., Song S.J., Yassour M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392.
23. Grice E.A., Kong H.H., Conlan S., Deming C.B., Davis J., Young A.C., Bouffard G.G., Blakesley R.W., Murray P.R., Green E.D., et al. Topographical and temporal diversity of the human skin microbiome. Science 2009, 324:1190-1192. NISC Comparative Sequencing Program.
24. Haiser H.J., Gootenberg D.B., Chatman K., Sirasani G., Balskus E.P., Turnbaugh P.J. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013, 341:295-298.
25. Hamady M., Knight R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res. 2009, 19:1141-1152.
26. Hsiao E.Y., McBride S.W., Hsien S., Sharon G., Hyde E.R., McCue T., Codelli J.A., Chow J., Reisman S.E., Petrosino J.F., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155:1451-1463.
27. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214. Human Microbiome Project Consortium.
28. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 2011, 108:5354-5359.
29. Khosravi A., Yáñez A., Price J.G., Chow A., Merad M., Goodridge H.S., Mazmanian S.K. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014, 15:374-381.
30. Knights D., Parfrey L.W., Zaneveld J., Lozupone C., Knight R. Human-associated microbial signatures: examining their predictive value. Cell Host Microbe 2011, 10:292-296.
31. Kravchenko V.V., Kaufmann G.F., Mathison J.C., Scott D.A., Katz A.Z., Grauer D.C., Lehmann M., Meijler M.M., Janda K.D., Ulevitch R.J. Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. Science 2008, 321:259-263.
32. Langille M.G., Zaneveld J., Caporaso J.G., McDonald D., Knights D., Reyes J.A., Clemente J.C., Burkepile D.E., Vega Thurber R.L., Knight R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013, 31:814-821.
33. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546. MetaHIT consortium.
34. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl 1):4615-4622.
35. Lee S.M., Donaldson G.P., Mikulski Z., Boyajian S., Ley K., Mazmanian S.K. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013, 501:426-429.
36. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
37. Linares J.F., Gustafsson I., Baquero F., Martinez J.L. Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. USA 2006, 103:19484-19489.
38. Ling Z., Li Z., Liu X., Cheng Y., Luo Y., Tong X., Yuan L., Wang Y., Sun J., Li L., Xiang C. Altered fecal microbiota composition associated with food allergy in infants. Appl. Environ. Microbiol. 2014, 80:2546-2554.
39. Mackey D., McFall A.J. MAMPs and MIMPs: proposed classifications for inducers of innate immunity. Mol. Microbiol. 2006, 61:1365-1371.
40. Martin F.P., Dumas M.E., Wang Y., Legido-Quigley C., Yap I.K., Tang H., Zirah S., Murphy G.M., Cloarec O., Lindon J.C., et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 2007, 3:112.
41. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
42. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
43. Moree W.J., Phelan V.V., Wu C.H., Bandeira N., Cornett D.S., Duggan B.M., Dorrestein P.C. Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc. Natl. Acad. Sci. USA 2012, 109:13811-13816.
44. Moroboshi T., Ebata A., Nakazawa S., Kato N., Ikeda T. N-acyl Homoserine Lactone-Producing or -Degrading Bacteria Isolated from the Intestinal Flora of Ayu Fish (Plecoglossus altivelis). Microbes Environ. 2005, 4:264-268.
45. Muegge B.D., Kuczynski J., Knights D., Clemente J.C., González A., Fontana L., Henrissat B., Knight R., Gordon J.I. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011, 332:970-974.
46. Nicholson J.K., Holmes E., Wilson I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3:431-438.
47. Ochoa-Repáraz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., Kasper L.H. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010, 3:487-495.
48. Pédron T., Mulet C., Dauga C., Frangeul L., Chervaux C., Grompone G., Sansonetti P.J. A crypt-specific core microbiota resides in the mouse colon. MBio 2012, 3. 10.1128/mBio.00116-12.
49. Peterson J., Garges S., Giovanni M., McInnes P., Wang L., Schloss J.A., Bonazzi V., McEwen J.E., Wetterstrand K.A., Deal C., et al. The NIH Human Microbiome Project. Genome Res. 2009, 19:2317-2323. NIH HMP Working Group.
50. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65. MetaHIT Consortium.
51. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
52. Quehenberger O., Armando A.M., Brown A.H., Milne S.B., Myers D.S., Merrill A.H., Bandyopadhyay S., Jones K.N., Kelly S., Shaner R.L., et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J.Lipid Res. 2010, 51:3299-3305.
53. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
54. Rath C.M., Alexandrov T., Higginbottom S.K., Song J., Milla M.E., Fischbach M.A., Sonnenburg J.L., Dorrestein P.C. Molecular analysis of model gut microbiotas by imaging mass spectrometry and nanodesorptionelectrospray ionization reveals dietary metabolite transformations. Anal. Chem. 2012, 84:9259-9267.
55. Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341:1241214.
56. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 2010, 107:12204-12209.
57. Scher J.U., Sczesnak A., Longman R.S., Segata N., Ubeda C., Bielski C., Rostron T., Cerundolo V., Pamer E.G., Abramson S.B., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013, 2:e01202.
58. Schloissnig S., Arumugam M., Sunagawa S., Mitreva M., Tap J., Zhu A., Waller A., Mende D.R., Kultima J.R., Martin J., et al. Genomic variation landscape of the human gut microbiome. Nature 2013, 493:45-50.
59. Shevchenko A., Simons K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 2010, 11:593-598.
60. Smith M.I., Yatsunenko T., Manary M.J., Trehan I., Mkakosya R., Cheng J., Kau A.L., Rich S.S., Concannon P., Mychaleckyj J.C., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013, 339:548-554.
61. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
62. Swearingen M.C., Sabag-Daigle A., Ahmer B.M. Are there acyl-homoserine lactones within mammalian intestines?. J.Bacteriol. 2013, 195:173-179.
63. Thorburn A.N., Macia L., Mackay C.R. Diet, Metabolites, and"Western-Lifestyle" Inflammatory Diseases. Immunity 2014, 40:833-842. this issue.
64. Tinh N.T., Asanka Gunasekara R.A., Boon N., Dierckens K., Sorgeloos P., Bossier P. N-acyl homoserine lactone-degrading microbial enrichment cultures isolated from Penaeus vannamei shrimp gut and their probiotic properties in Brachionus plicatilis cultures. FEMS Microbiol. Ecol. 2007, 62:45-53.
65. Traxler M.F., Watrous J.D., Alexandrov T., Dorrestein P.C., Kolter R. Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolome. MBio 2013, 4.
66. Trompette A., Gollwitzer E.S., Yadava K., Sichelstiel A.K., Sprenger N., Ngom-Bru C., Blanchard C., Junt T., Nicod L.P., Harris N.L., Marsland B.J. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014, 20:159-166.
67. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
68. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
69. Ubeda C., Lipuma L., Gobourne A., Viale A., Leiner I., Equinda M., Khanin R., Pamer E.G. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J.Exp. Med. 2012, 209:1445-1456.
70. Viaud S., Saccheri F., Mignot G., Yamazaki T., Daillère R., Hannani D., Enot D.P., Pfirschke C., Engblom C., Pittet M.J., et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013, 342:971-976.
71. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., Sitaraman S.V., Knight R., Ley R.E., Gewirtz A.T. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
72. Wang H., Cai T., Weng M., Zhou J., Cao H., Zhong Z., Zhu J. Conditional production of acyl-homoserine lactone-type quorum-sensing signals in clinical isolates of enterobacteria. J.Med. Microbiol. 2006, 55:1751-1753.
73. Yang Y.L., Xu Y., Straight P., Dorrestein P.C. Translating metabolic exchange with imaging mass spectrometry. Nat. Chem. Biol. 2009, 5:885-887.
74. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
75. Zelante T., Iannitti R.G., Cunha C., De Luca A., Giovannini G., Pieraccini G., Zecchi R., D'Angelo C., Massi-Benedetti C., Fallarino F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39:372-385.